Efficacy and Safety of Ruxolitinib Cream for the Treatment of Moderate to Severe Chronic Hand Eczema: Top-Line Results From a 16-Week, Multicenter, Randomized, Double-Blind Study. (2024). SKIN The Journal of Cutaneous Medicine, 8(6), s500. https://doi.org/10.25251/skin.8.supp.500